Please check your internet connection and try again.
# IV Dexamethasone
## Overview
Dexamethasone is a potent synthetic corticosteroid with anti-inflammatory and immunosuppressive effects. It is available in intravenous formulation.
## Primary Indications
* Allergic states
* Dermatologic diseases
* Endocrine disorders
* Gastrointestinal diseases
* Hematologic disorders
* Neoplastic conditions (adjunctive therapy)
* Nervous system conditions (e.g., cerebral edema)
* Ophthalmic diseases
* Renal diseases
* Respiratory diseases
* Rheumatic disorders
* Rheumatic disorders
## Adult Dosing
Dosing is highly variable depending on the indication and severity. Common starting doses range from **1 mg to 12 mg intravenously every 12 to 24 hours**. Higher doses may be used for specific conditions like cerebral edema or septic shock. Maximum daily doses are typically not strictly defined but depend on clinical response and tolerability. Specific protocols often dictate dosing for conditions such as septic shock.
## Pediatric Dosing
Dosing is also highly variable and depends on the indication, age, and weight. Common regimens include **0.15 mg/kg/day intravenously divided every 6 to 12 hours**, or **0.4 mg/kg/day divided every 6 to 12 hours**. Individual doses often range from **1 mg to 6 mg**. Always refer to specific pediatric guidelines or institutional protocols.
## Dose Adjustments
No specific dose adjustments are routinely recommended for hepatic or renal impairment, as dexamethasone is not extensively metabolized by the liver and is not cleared by the kidneys in significant amounts. However, prolonged use and higher doses increase the risk of adverse effects.
## Contraindications
* Systemic fungal infections
* Hypersensitivity to dexamethasone or other corticosteroids
## Adverse Effects
Common adverse effects include hyperglycemia, insomnia, mood changes, increased appetite, fluid retention, and increased susceptibility to infections. Long-term use can lead to Cushingoid features, osteoporosis, adrenal suppression, peptic ulceration, and growth suppression in children.
## Key Drug Interactions
* **CYP3A4 inducers** (e.g., rifampin, phenytoin, carbamazepine, phenobarbital): May decrease dexamethasone efficacy.
* **CYP3A4 inhibitors** (e.g., ketoconazole, erythromycin): May increase dexamethasone levels.
* **Diuretics (non-potassium sparing)**: May potentiate hypokalemia.
* **Anticoagulants**: May alter anticoagulant effects.
* **Live vaccines**: Increased risk of disseminated infection.
## Monitoring
* Blood glucose levels
* Electrolytes (especially potassium)
* Signs of infection
* Signs of Cushingoid syndrome with prolonged use
* Growth in pediatric patients with long-term therapy
* Adrenal function (if abruptly discontinued after prolonged use)
## Clinical Pearls
* Administer IV dexamethasone slowly to minimize risk of adverse reactions.
* For cerebral edema, loading doses followed by a tapering regimen are common.
* Taper corticosteroids gradually to avoid adrenal insufficiency, especially after prolonged therapy.
* Be aware of the potential for masking infections.
***
**Disclaimer**: This information is intended for healthcare professionals. Always consult the most current prescribing information, institutional guidelines, and peer-reviewed literature for complete and up-to-date details before making any clinical decisions.
